Effect of the Low Level Light Therapy on measurable variables of the autonomic nervous system in people with Cerebral Palsy

Not Applicable

Recruiting

• Conditions: Cerebral Palsy; Physiological stress; Sleep quality; Obstructive sleep apnea; Articular range of motion; Basal metabolism; A08.800.050; Inflammation mediators; Biomarkers; Melatonin

• Registration Number: RBR-9jf5bmj
• Lead Sponsor: Centro de Estudos da Educação e Saúde - CER II - Universidade Estadual Paulista

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-05-16
• Last Update Posted: 27 May 2024
• Study Completion: 2026-03-01

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Age between 5 and 20 years; both genders; cerebral palsy diagnosys; at levels I to V of the Gross Motor Function Classification System (GMFCS)

Exclusion Criteria

Individuals with neoplastic areas; bleeding episode; thermal sensitivity disorders; use of photosensitive drugs; have more than two consecutive faults

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
We expect that photobiomodulation therapy may promote an autonomic balance, normalize levels of stress and inflammation-related biomarkers, act on melatonin, and improve sleep quality; assessed through the Children's Sleep Disturbance Scale, as well as by the Biologix device; reduce stool dryness and the interval of days between evacuations in individuals who present initial alterations, and increase the range of motion of passive knee extension

Secondary Outcome Measures

Name	Time	Method
Secondary outcomes are not expected.<br>